Arrowpoint Investment Partners (Singapore) Pte. Ltd. 13F Portfolio

CIK 2032331 Filing since Q4 2024 Q2 2026 filed Aug 13, 2026
Holdings as of Jun 30, 2026, from the 13F filed Aug 13, 2026.

Portfolio Snapshot

108 positions · Q2 2026

Arrowpoint Investment Partners (Singapore) Pte. Ltd. reported 108 positions worth $326.84M for the quarter ended Jun 30, 2026, up 426.9% on the prior quarter. It opened 74 new positions, added to 18, trimmed 16 and exited 28. Its largest holding is Citigroup Inc at 10.1% of the portfolio.

Portfolio Value
$326.84M
+426.9% QoQ · +606.2% YoY
Positions
108
74 new · 28 sold out
Top 10 Concentration
66.5%
of portfolio value
Largest Position
C 10.1%
Citigroup Inc
Net Buying
+$255.78M
$287.16M bought · $31.39M sold
Turnover
16.1%
of the portfolio traded
Top Sector
Technology
29.4% of value
Track Record
7
quarters on file since Q4 2024

Portfolio Value & Positions

Value Positions

Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.

Sector Allocation

12 sectors
29.41%
Technology
Technology29.41%
Healthcare25.49%
Other10.06%
Financial Services9.72%
Industrials9.64%
Utilities7.78%
Energy7.56%
Consumer Discretionary0.156%
Consumer Staples0.077%
Communication Services0.05%
Basic Materials0.038%
Real Estate0.016%

Quarterly Buying & Selling

Bought Sold

Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.

Position Changes

How many positions were opened, added to, trimmed or closed each quarter.

Sector Allocation Over Time

Share of reported value in each sector at every quarter end.

TechnologyHealthcareOtherFinancial ServicesIndustrialsUtilitiesEnergyConsumer DiscretionaryConsumer StaplesCommunication ServicesBasic MaterialsReal Estate

Largest Buys

Q2 2026
Holding Change Change % Trade Value Weight
C Citigroup Inc +235.0K – $32.90M 10.06%
GS Goldman Sachs Group Inc +31.0K – $31.32M 9.58%
GPN Global Payments Inc +384.1K – $27.87M 8.53%
NSC Norfolk Southern Corp +81.3K – $25.59M 7.83%
AEP American Electric Power Co Inc +186.0K – $25.44M 7.78%
NVDA Nvidia Corp +125.5K – $25.12M 7.69%
XOM ExxonMobil Holdings Corp +179.3K – $24.51M 7.5%
MU Micron Technology Inc +6,519 – $7.52M 2.3%
INTC Intel Corp +33.4K – $4.66M 1.43%
SNDK Sandisk Corp +2,008 – $4.57M 1.4%

Largest Sells

Q2 2026
Holding Change Change % Trade Value Weight
ASX ASE Technology Holding Co., Ltd. -179.5K -100.0% $3.89M Exited
ASND Ascendis Pharma A/S -11.8K -100.0% $2.71M Exited
IONS Ionis Pharmaceuticals Inc -26.7K -68.4% $2.11M 0.299%
PFE Pfizer Inc -71.3K -100.0% $2.00M Exited
REGN Regeneron Pharmaceuticals, Inc. -2,502 -100.0% $1.93M Exited
JNJ Johnson & Johnson -7,902 -100.0% $1.93M Exited
AMGN Amgen Inc -4,934 -100.0% $1.74M Exited
GILD Gilead Sciences, Inc. -12.0K -100.0% $1.67M Exited
VRTX Vertex Pharmaceuticals Inc / Ma -3,412 -100.0% $1.52M Exited
BMRN Biomarin Pharmaceutical Inc -21.7K -44.5% $1.24M 0.473%

New Positions

Q2 2026
Holding Shares Trade Value Weight
C Citigroup Inc +235.0K $32.90M 10.06%
GS Goldman Sachs Group Inc +31.0K $31.32M 9.58%
GPN Global Payments Inc +384.1K $27.87M 8.53%
NSC Norfolk Southern Corp +81.3K $25.59M 7.83%
AEP American Electric Power Co Inc +186.0K $25.44M 7.78%
NVDA Nvidia Corp +125.5K $25.12M 7.69%
XOM ExxonMobil Holdings Corp +179.3K $24.51M 7.5%
MU Micron Technology Inc +6,519 $7.52M 2.3%
INTC Intel Corp +33.4K $4.66M 1.43%
SNDK Sandisk Corp +2,008 $4.57M 1.4%

Closed Positions

Q2 2026
Holding Shares Sold Trade Value Prior Weight
ASX ASE Technology Holding Co., Ltd. -179.5K $3.89M 6.27%
ASND Ascendis Pharma A/S -11.8K $2.71M 4.36%
PFE Pfizer Inc -71.3K $2.00M 3.23%
REGN Regeneron Pharmaceuticals, Inc. -2,502 $1.93M 3.12%
JNJ Johnson & Johnson -7,902 $1.93M 3.11%
AMGN Amgen Inc -4,934 $1.74M 2.8%
GILD Gilead Sciences, Inc. -12.0K $1.67M 2.69%
VRTX Vertex Pharmaceuticals Inc / Ma -3,412 $1.52M 2.46%
OSG Octave Specialty Group Inc -139.2K $647.13K 1.04%
AXGN Axogen, Inc. -16.3K $539.12K 0.869%
Holdings · Q2 2026

108 Positions

As ofJun 30, 2026
Value$326.84M
Top 1066.5%
Avg position$3.03M
# Activity
93 more holdings Create a free account to keep reading this institution’s full portfolio.
Showing 1–15 of 108 positions 13F filings on SEC EDGAR

Tip. Select a row to see that position’s full history at Arrowpoint Investment Partners (Singapore) Pte.

About Arrowpoint Investment Partners (Singapore) Pte. Ltd.’s 13F Portfolio

What are Arrowpoint Investment Partners (Singapore) Pte. Ltd.’s largest holdings?

As of its Q2 2026 13F filing, Arrowpoint Investment Partners (Singapore) Pte. Ltd.’s five largest positions were Citigroup Inc (C) at 10.1%, Goldman Sachs Group Inc (GS) at 9.6%, Global Payments Inc (GPN) at 8.5%, Norfolk Southern Corp (NSC) at 7.8%, American Electric Power Co Inc (AEP) at 7.8% of the reported portfolio.

How much is Arrowpoint Investment Partners (Singapore) Pte. Ltd.’s portfolio worth?

Arrowpoint Investment Partners (Singapore) Pte. Ltd. reported a 13F portfolio worth $326.84M across 108 positions for Q2 2026. That is up 426.9% from the previous quarter.

What did Arrowpoint Investment Partners (Singapore) Pte. Ltd. buy in Q2 2026?

Its largest purchases by value were Citigroup Inc ($32.90M), Goldman Sachs Group Inc ($31.32M), Global Payments Inc ($27.87M). It opened 74 new positions.

What did Arrowpoint Investment Partners (Singapore) Pte. Ltd. sell in Q2 2026?

Its largest sales by value were ASE Technology Holding Co., Ltd. ($3.89M), Ascendis Pharma A/S ($2.71M), Ionis Pharmaceuticals Inc ($2.11M). It exited 28 positions entirely.

Where does this data come from?

From the Form 13F-HR reports Arrowpoint Investment Partners (Singapore) Pte. Ltd. files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.

Similar-Sized Institutions

by reported 13F value

13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.